Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-002265
Accepted
2021-06-09 00:15:08
Documents
1
Effectiveness Date
2021-06-08
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 598
  Complete submission text file 9999999995-21-002265.txt   1724
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-256614 | Film No.: 211003864
SIC: 2834 Pharmaceutical Preparations